Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 2 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 2

From: The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy

Fig. 2

Axial non-contrast CT and PET-CT images for a 72-year-old male patient with history of prostate cancer for which he had operation, chemotherapy, and hormonal therapy. Images a and b (baseline study) showed no 68Ga-PSMA activity at the operative bed with no significant changes in images c and d (follow up study) (red arrows). Images e and f (baseline study) showed 68Ga-PSMA activity by enlarged metastatic right hilar lymph node measuring 14 mm with SUVmax = 11.7 and showed activity regression in images g and h (follow up study) with SUVmax = 7.3 (blue arrows)

Back to article page